Osiris Therapeutics, Inc. Corrects Certain Inaccuracies in Media Reports
COLUMBIA, Md.--(BUSINESS WIRE)--Osiris Therapeutics, Inc. (NASDAQ: OSIR), issued a statement today correcting certain inaccuracies in media reports following the announcement of its favorable agreement with the United States Food and Drug Administration (FDA) regarding Grafix®.
Help employers find you! Check out all the jobs and post your resume.